Samsung Biologics Names John Rim President and CEO

Facebook X LinkedIn Email
INCHEON, South Korea, Dec. 22, 2020 — Samsung Biologics named John Rim as its president and CEO effectively immediately. Since 2018, he has served as executive vice president at Samsung Biologics. Previously Rim worked for Genentech/Roche in a variety of senior global leadership roles. He also served in leadership roles at Astellas Pharma.

Published: December 2020
BusinessBiophotonicspharmaceuticalSamsungSamsung BiologicsmicrobiologyMicroscopyspectroscopytestingappointmentscompany appointmentsCEOCEO appointmentpeopleAsia-Pacific

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.